Literature DB >> 23388546

Association study of 71 European Crohn's disease susceptibility loci in a Japanese population.

Atsushi Hirano1, Keiko Yamazaki, Junji Umeno, Kyota Ashikawa, Masayuki Aoki, Takayuki Matsumoto, Shotaro Nakamura, Toshiharu Ninomiya, Toshiyuki Matsui, Fumihito Hirai, Takaaki Kawaguchi, Masakazu Takazoe, Hiroki Tanaka, Satoshi Motoya, Yutaka Kiyohara, Takanari Kitazono, Yusuke Nakamura, Naoyuki Kamatani, Michiaki Kubo.   

Abstract

BACKGROUND: A large-scale meta-analysis of a series of European genome-wide association studies revealed 71 susceptibility loci for Crohn's disease (CD). However, it is not clear whether these susceptibility loci are also shared with Japanese populations.
METHODS: We genotyped 71 single-nucleotide polymorphisms (SNPs) comprising 1311 CD cases and 6585 controls of Japanese descent, and their associations with CD were evaluated using the Cochran-Armitage trend test. In addition, genotype-phenotype analyses were conducted on the SNPs showing associations with Japanese CD based on the Montreal classification.
RESULTS: Twenty-seven SNPs showed at least nominal association (P < 0.05) and 11 of them remained significant even after Bonferroni correction (P < 0.0007). Despite high statistical power, we could not find any association in 17 loci. Moreover, SNPs in 9 loci were rare or absent in the Japanese population. Genetic variations involved in the innate immune system (NOD2, ATG16L1, and IRGM) showed no association with CD susceptibility in the Japanese population. Genotype-phenotype analyses showed that rs3810936, a marker of TNFSF15, correlated with severe CD phenotypes.
CONCLUSIONS: Our study suggests that there is a differential genetic background of CD susceptibility between Japanese and European populations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23388546     DOI: 10.1097/MIB.0b013e31828075e7

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  31 in total

1.  Genetic characteristics of inflammatory bowel disease in a Japanese population.

Authors:  Yuta Fuyuno; Keiko Yamazaki; Atsushi Takahashi; Motohiro Esaki; Takaaki Kawaguchi; Masakazu Takazoe; Takayuki Matsumoto; Toshiyuki Matsui; Hiroki Tanaka; Satoshi Motoya; Yasuo Suzuki; Yutaka Kiyohara; Takanari Kitazono; Michiaki Kubo
Journal:  J Gastroenterol       Date:  2015-10-28       Impact factor: 7.527

2.  Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.

Authors:  Chengrui Huang; Talin Haritunians; David T Okou; Dermot P B McGovern; Steven R Brant; Subra Kugathasan; David J Cutler; Michael E Zwick; Kent D Taylor; Lisa W Datta; Joseph C Maranville; Zhenqiu Liu; Shannon Ellis; Pankaj Chopra; Jonathan S Alexander; Robert N Baldassano; Raymond K Cross; Themistocles Dassopoulos; Tanvi A Dhere; Richard H Duerr; John S Hanson; Jason K Hou; Sunny Z Hussain; Kim L Isaacs; Kelly E Kachelries; Howard Kader; Michael D Kappelman; Jeffrey Katz; Richard Kellermayer; Barbara S Kirschner; John F Kuemmerle; Archana Kumar; John H Kwon; Mark Lazarev; Peter Mannon; Dedrick E Moulton; Bankole O Osuntokun; Ashish Patel; John D Rioux; Jerome I Rotter; Shehzad Saeed; Ellen J Scherl; Mark S Silverberg; Ann Silverman; Stephan R Targan; John F Valentine; Ming-Hsi Wang; Claire L Simpson; S Louis Bridges; Robert P Kimberly; Stephen S Rich; Judy H Cho; Anna Di Rienzo; Linda W H Kao
Journal:  Gastroenterology       Date:  2015-08-14       Impact factor: 22.682

3.  NOD2 modulates immune tolerance via the GM-CSF-dependent generation of CD103+ dendritic cells.

Authors:  David Prescott; Charles Maisonneuve; Jitender Yadav; Stephen J Rubino; Stephen E Girardin; Dana J Philpott
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-29       Impact factor: 11.205

4.  A Genome-wide Association Study Identifying RAP1A as a Novel Susceptibility Gene for Crohn's Disease in Japanese Individuals.

Authors:  Yoichi Kakuta; Yosuke Kawai; Takeo Naito; Atsushi Hirano; Junji Umeno; Yuta Fuyuno; Zhenqiu Liu; Dalin Li; Takeru Nakano; Yasuhiro Izumiyama; Ryo Ichikawa; Daisuke Okamoto; Hiroshi Nagai; Shin Matsumoto; Katsutoshi Yamamoto; Naonobu Yokoyama; Hirofumi Chiba; Yusuke Shimoyama; Motoyuki Onodera; Rintaro Moroi; Masatake Kuroha; Yoshitake Kanazawa; Tomoya Kimura; Hisashi Shiga; Katsuya Endo; Kenichi Negoro; Jun Yasuda; Motohiro Esaki; Katsushi Tokunaga; Minoru Nakamura; Takayuki Matsumoto; Dermot P B McGovern; Masao Nagasaki; Yoshitaka Kinouchi; Tooru Shimosegawa; Atsushi Masamune
Journal:  J Crohns Colitis       Date:  2019-04-26       Impact factor: 9.071

5.  Common NOD2/CARD15 and TLR4 Polymorphisms Are Associated with Crohn's Disease Phenotypes in Southeastern Brazilians.

Authors:  Yolanda F M Tolentino; Paula Peruzzi Elia; Homero Soares Fogaça; Antonio José V Carneiro; Cyrla Zaltman; Rodrigo Moura-Neto; Ronir Raggio Luiz; Maria da Gloria C Carvalho; Heitor S de Souza
Journal:  Dig Dis Sci       Date:  2016-04-23       Impact factor: 3.199

6.  LRRK2 but not ATG16L1 is associated with Paneth cell defect in Japanese Crohn's disease patients.

Authors:  Ta-Chiang Liu; Takeo Naito; Zhenqiu Liu; Kelli L VanDussen; Talin Haritunians; Dalin Li; Katsuya Endo; Yosuke Kawai; Masao Nagasaki; Yoshitaka Kinouchi; Dermot Pb McGovern; Tooru Shimosegawa; Yoichi Kakuta; Thaddeus S Stappenbeck
Journal:  JCI Insight       Date:  2017-03-23

Review 7.  Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD.

Authors:  Noam Jacob; Stephan R Targan; David Q Shih
Journal:  United European Gastroenterol J       Date:  2016-05-10       Impact factor: 4.623

Review 8.  Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utility.

Authors:  Byong Duk Ye; Dermot P B McGovern
Journal:  Expert Rev Clin Immunol       Date:  2016-06-15       Impact factor: 4.473

9.  What Role Does Mycobacterium avium subsp. paratuberculosis Play in Crohn's Disease?

Authors:  Horacio Bach
Journal:  Curr Infect Dis Rep       Date:  2015-02       Impact factor: 3.725

10.  The Crohn's disease-associated polymorphism in ATG16L1 (rs2241880) reduces SHIP gene expression and activity in human subjects.

Authors:  E N Ngoh; H K Brugger; M Monajemi; S C Menzies; A F Hirschfeld; K L Del Bel; K Jacobson; P M Lavoie; S E Turvey; L M Sly
Journal:  Genes Immun       Date:  2015-07-30       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.